Assertiveness and emotion-management difficulties in adults with Tourette syndrome
Official title: Epidemiology of Assertiveness and Emotion Management Disorders in People With Tourette's Syndrome
Run by University Hospital, Clermont-Ferrand · NCT06136572 · Data updated 2026-11-12
This will test how common assertiveness difficulties are in adults with Tourette syndrome by asking them to complete online questionnaires.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 350 (estimated) |
| Sponsor | University Hospital, Clermont-Ferrand Academic / other |
| Locations | 1 site (Clermont-Ferrand, France) |
| Status | Recruiting |
| Started | May 6, 2024 |
| Main results expected | May 5, 2026 |
| Study ends | November 5, 2026 |
| Registry record updated | February 27, 2026 |
| Trial ID | NCT06136572 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age 18+) with a diagnosis of Tourette syndrome who can complete electronic questionnaires on their own are ideal candidates.
✕Probably not a fit
People under legal protection, those unable to complete questionnaires independently, and children under 18 would not be eligible and therefore would not benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with a diagnosis of Tourette syndrome will complete a battery of electronic questionnaires including the Rathus Assertiveness Schedule, measures of tic severity, quality of life, self-esteem, and screening for depression and anxiety. The primary aim is to quantify the proportion of participants who meet predefined criteria for assertiveness difficulties and to explore associations with tic severity and comorbid symptoms. Individuals under legal protection or unable to complete questionnaires independently are excluded. Recruitment is based at CHU Clermont-Ferrand and responses will be analyzed to describe prevalence and correlates of assertiveness and emotion-management problems in this population.
Why it matters
Potential benefit: If successful, the results could clarify how common these problems are and help guide referrals to psychosocial support or targeted therapies for adults with Tourette syndrome.
How similar studies have gone: Previous questionnaire-based research has documented social and emotional comorbidities in Tourette syndrome, but focused work specifically on assertiveness is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Tourette syndrome * Participants aged 18 years or over Exclusion Criteria: * Participants under legal protection * Inability to complete questionnaires alone
Where it's running
-
CHU Clermont-Ferrand
Clermont-Ferrand, France, France Recruiting
Study contacts
- Principal investigator: Isabelle JALENQUES — University Hospital, Clermont-Ferrand
- Study coordinator: Lise Laclautre
- Email: promo_interne_drci@chu-clermontferrand.fr
- Phone: 334.73.754.963
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nature- and activity-based group programs for neurodivergent children and youth in Agder
This project will try outdoor and activity-based group programs to see if they help children and teens with ADHD, autism, Tourette's, and related neurodivergent challenges feel better, gain confidence, and do better in daily life.
-
Study of brain activity in patients with Tourette Syndrome
This study is testing how brain activity changes in adults with severe Tourette Syndrome who are getting deep brain stimulation to better understand their tics.
-
Personalized deep brain stimulation for Tourette syndrome
This study is testing if personalized deep brain stimulation can help people with Tourette syndrome reduce their tics and improve related issues like anxiety and attention problems.
-
Cognitive-psychophysiological therapy, with or without biofeedback, for tics in young people with Tourette's
This project tests whether adding biofeedback to cognitive-psychophysiological therapy helps reduce tics in 14–21-year-olds with Tourette's.
-
Personalized neurostimulation for Tourette's Syndrome
This study is testing a personalized brain stimulation treatment for adults with Tourette's Syndrome who haven't found relief from other therapies to see if it can help reduce their severe tics.
-
Understanding changes in Tourette Syndrome
This study is trying to learn how Tourette Syndrome and tic disorders change over time in kids by using new technology to track their symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.